Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Remember that clinical trial that Mike was part of last April, that involved Puffing Glucagon Up Your Nose?
Well, the Canada-based makers of that exciting no-needle emergency rescue glucagon have come out of stealth mode, with a brand-new website for the company called Locemia (a mashup of “low blood sugar” and “hypoglycemia”), announcing their mission to spread awareness about hypoglycemia and “expand the community of people around those who use insulin to feel confident come to the aid of someone having a low.”
“We want to make it easy for everyone to be able to help anyone who uses insulin anywhere, anytime,” says Locemia co-creator and chairman Robert Oringer, an entrepreneur with a long history in the diabetes industry.
Last week at the ATTD Conference in Paris, they announced results of Phase 3 adult clinical trials “showing that this new, user-friendly, needle-free nasal glucagon delivery system is as effective as the traditional injected form of glucagon.” The research was supported by Helmsley Charitable Trust and T1D Exchange, which helped coordinate with a network of research centers around the country.
http://www.healthline.com/diabetesmine/locemia-and-its-new-approach-rescue-glucagon-your-nose#1
Sounds promising! 🙂
Well, the Canada-based makers of that exciting no-needle emergency rescue glucagon have come out of stealth mode, with a brand-new website for the company called Locemia (a mashup of “low blood sugar” and “hypoglycemia”), announcing their mission to spread awareness about hypoglycemia and “expand the community of people around those who use insulin to feel confident come to the aid of someone having a low.”
“We want to make it easy for everyone to be able to help anyone who uses insulin anywhere, anytime,” says Locemia co-creator and chairman Robert Oringer, an entrepreneur with a long history in the diabetes industry.
Last week at the ATTD Conference in Paris, they announced results of Phase 3 adult clinical trials “showing that this new, user-friendly, needle-free nasal glucagon delivery system is as effective as the traditional injected form of glucagon.” The research was supported by Helmsley Charitable Trust and T1D Exchange, which helped coordinate with a network of research centers around the country.
http://www.healthline.com/diabetesmine/locemia-and-its-new-approach-rescue-glucagon-your-nose#1
Sounds promising! 🙂